Precigen, Inc. (PGEN) Stock Forecast
Data as of May 9, 2026Healthcare · Current price $4.21 (+1.57%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
PGEN vs Sector & Market
| Metric | PGEN | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 3 | 8 | 19 |
| Target Upside | +42.4% | +1710.9% | +16.4% |
| P/E Ratio | -5.02 | 3.30 | 27.60 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $22M | $26M | $30M | 2 |
| 2026-09-30 | $26M | $31M | $38M | 1 |
| 2026-12-31 | $31M | $37M | $45M | 1 |
| 2027-12-31 | $191M | $209M | $227M | 2 |
| 2028-12-31 | $266M | $320M | $372M | 1 |
| 2029-12-31 | $363M | $436M | $507M | 1 |
| 2030-12-31 | $483M | $580M | $675M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $-0.03 | $-0.02 | $-0.01 | 2 |
| 2026-09-30 | $-0.01 | $-0.01 | $-0.01 | 1 |
| 2026-12-31 | $0.01 | $0.01 | $0.01 | 1 |
| 2027-12-31 | $0.12 | $0.15 | $0.18 | 2 |
| 2028-12-31 | $0.34 | $0.44 | $0.53 | 1 |
| 2029-12-31 | $0.54 | $0.69 | $0.84 | 1 |
| 2030-12-31 | $0.80 | $1.02 | $1.24 | 1 |
Frequently Asked Questions
What is the analyst consensus for PGEN?
The consensus among 3 analysts covering Precigen, Inc. (PGEN) is Buy with an average price target of $6.00.
What is the highest price target for PGEN?
The highest analyst price target for PGEN is $6.00.
What is the lowest price target for PGEN?
The lowest analyst price target for PGEN is $6.00.
How many analysts cover PGEN?
3 analysts have issued ratings for Precigen, Inc. in the past 12 months.
Is PGEN a buy or sell right now?
Based on 3 analyst ratings, PGEN has a consensus rating of Buy (2.00/5) with a +42.4% upside to the consensus target of $6.00.
What are the earnings estimates for PGEN?
Analysts estimate PGEN will report EPS of $-0.02 for the period ending 2026-06-30, with revenue estimated at $26M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.